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The Yale Global Tic Severity Scale (YGTSS) is a clinician-rated instrument considered
as the gold standard for assessing tics in patients with Tourette’s Syndrome and
other tic disorders. Previous psychometric investigations of the YGTSS exhibit different
limitations such as small sample sizes and insufficient methods. To overcome these
shortcomings, we used a subsample of the large-scale “European Multicentre Tics in
Children Study” (EMTICS) including 706 children and adolescents with a chronic tic
disorder and investigated convergent, discriminant and factorial validity, as well as internal
consistency of the YGTSS. Our results confirm acceptable convergent and good to very
good discriminant validity, respectively, indicated by a sufficiently high correlation of the
YGTSS total tic score with the Clinical Global Impression Scale for tics (rs = 0.65) and only
low to medium correlations with clinical severity ratings of attention deficit/hyperactivity
symptoms (rs = 0.24), obsessive–compulsive symptoms (rs = 27) as well as internalizing
symptoms (rs = 0.27). Internal consistency was found to be acceptable ( = 0.58
for YGTSS total tic score). A confirmatory factor analysis supports the concept of
the two factors “motor tics” and “phonic tics,” but still demonstrated just a marginal
model fit (root mean square error of approximation = 0.09 [0.08; 0.10], comparative
fit index = 0.90, and Tucker Lewis index = 0.87). A subsequent analysis of local
misspecifications revealed correlated measurement errors, suggesting opportunities for
improvement regarding the item wording. In conclusion, our results indicate acceptable
psychometric quality of the YGTSS. However, taking the wide use and importance of
the YGTSS into account, our results suggest the need for further investigations and
improvements of the YGTSS. In addition, our results show limitations of the global severity
score as a sum score indicating that the separate use of the total tic score and the
impairment rating is more beneficial.
Keywords: Tourette’s syndrome (TS), YGTSS = Yale Global Tic Severity Scale, psychometric properties, internal
consistency, confirmatory factor analysis
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INTRODUCTION
Tics are defined as rapid, repetitive, non-rhythmic movements
or vocalizations (1). The nature of tics with their heterogeneous
presentation as well as waxing and waning course is complex
(2) and an accurate assessment of tic severity is thus challenging
(3). The Yale Global Tic Severity Scale [YGTSS (4)] is a semi-
structured clinical interview and currently the gold standard
for assessing the severity of tics in children and adults (5).
The YGTSS enables evaluations of number, frequency, intensity,
complexity, and interference of motor and phonic tics, covering
the past week. Each domain is scored on a 6-point scale (range
0–5) with a separate rating for “overall impairment” regarding
the subject’s daily life and activities (4). Five sum scores can be
created: the total motor tic score (range 0–25), the total phonic
tic score (range 0–25), the total tic score (TTS; sum of the
total motor tic score plus the total phonic tic score), the overall
impairment rating (one item; range 0–50), and the global severity
score (GSS; sum of the TTS plus the overall impairment rating,
range 0–100). Recommendations which score is preferable as a
primary endpoint in studies or for the assessment of individual
cases in clinical practice have not yet been formulated. However,
most studies use the TTS for the assessment of tic severity.
Since an assessment instrument provides the basis for all
subsequent evaluations and results, it should prove to be both
reliable and valid, as verified by psychometric investigations
(e.g., examination of internal consistency, factorial as well as
convergent and discriminant validity).
Previous studies have demonstrated very good internal
consistency of the YGTSS (4, 6–8). However, previous studies
were limited by the use of Cronbach’s Alpha (α) for the
calculation of internal consistency, since it has numerous well-
documented deficiencies (9–12). Most importantly, a violation
of the assumptions underlying the use of α (e.g., uncorrelated
errors) may lead to strongly biased results (13–18). Accordingly,
Lee J. Cronbach himself criticized the extensive use of α
(19), particularly since there are alternative measures available
recommended by experts. If the sample and the number of items
are sufficiently large, McDonald’s Omega () is recommended
(20–22), as it does not require the fulfillment of assumptions,
such as uncorrelated errors, and is therefore not as susceptible
to producing biased results.
Factorial validity is examined by factor analyses, which can be
divided into exploratory factor analyses (EFA) and confirmatory
factor analyses (CFA). EFA’s are mainly used to reduce data and
identify a previously unknown factor structure. For example,
an EFA is useful in questionnaire development to reduce the
initial item pool and to examine the structure and number
of underlying latent factors. CFA’s aim to test a theoretically
assumed factor structure. Thus, if there is already a theory
about the factor structure (which may have arisen from a
previous EFA), a CFA can confirm (or disprove) this assumed
factor structure (23). Only two studies have examined the factor
structure of the YGTSS. Using principle component analysis (in
a broader sense a form of EFA), Leckman et al. (4) found a
two-factor structure (factor 1: motor tics; factor 2: phonic tics)
of the YGTSS. However, the factors of the model accounted
for only 8% of the total item variance, which leaves most
part of the variance unexplained. Only one study attempted to
confirm the proposed factor structure using CFA (7). In line
with the authors’ expectations, items intended to measure motor
tics showed high loadings on the “motor factor” and items
intended to measure phonic tics demonstrated high loadings
on the “phonic factor.” In addition, inter-factor correlations
were as expected. However, the model showed only a poor to
modest fit.
Considering the results on internal consistency (measured
with α) on the one hand and factorial validity on the other
hand, the following discrepancy becomes evident: Due to the
high loadings (4, 7) of the items in the factor model and the high
internal consistency (4, 6–8), a good to very goodmodel fit would
be expected. However, contrary to this, the model fit was shown
to be only poor to modest (7). The authors suggested the small
sample size of their study (n = 76) as a possible reason for this
discrepancy, which may have had a negative impact on the model
fit (7). They recommended replication in a larger sample, yet, to
date, this is lacking.
Other aspects of validity are convergent and discriminant
validity. Convergent validity, shown by a high correlation
of the instrument with measures that are supposed to
measure the same construct (in this case tic severity) was
usually examined by correlating the YGTSS scores with the
Clinical Global Impression Scale Severity (CGI-S) for tics (24).
Discriminant validity, shown by low or moderate correlation
of the instrument with measure that are supposed to measure
other constructs, was often examined by correlating the YGTSS
scores with severity assessments of comorbid symptoms, e.g.,
attention deficit/hyperactivity disorder (ADHD) symptoms (25)
or obsessive–compulsive disorder (OCD) symptoms (26) as
well as severity assessments of common co-occurring behavioral
problems like internalizing symptoms (27). Both convergent
and discriminant validity of the YGTSS have been investigated
extensively with excellent results in small samples (N = 28–105)
(4, 6, 7, 26).
In 2018, McGuire et al. (8) suggested some minor revisions
of the YGTSS (YGTSS-R) to selected anchor point descriptions
(especially regarding “frequency” and “complexity”) to promote
using the full range of scores in the domains. This was based on
the distribution of the YGTSS items in a large age-mixed sample
(516 children and 101 adults). However, aspects of validity were
not examined in this study.
In summary although several psychometric properties of
the YGTSS have been examined previously, most of these
studies included only small samples or used limited analyses.
In addition, factorial validity has hardly been investigated so
far. A thorough investigation of the psychometric properties is
important, because of the widespread use of the instrument and
its status as the gold standard for tic assessment (5). The present
study aimed to overcome the limitations of previous studies
and to supply more reliable information on the psychometric
properties of the YGTSS. Therefore, we utilized a subsample of
the large-scale “European Multicentre Tics in Children Study”
(EMTICS) (28) including 706 children and adolescents as well as
adequate statistical analyses to investigate internal consistency,
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We used the large dataset of EMTICS, which is a longitudinal
study that has been conducted between 2013 and 2018 in 16
European clinical centers and primarily aimed to examine the
role of genes, autoimmunity, and psychosocial stress on the onset
and course of tics. In EMTICS, children and adolescents with
Tourette’s syndrome (TS) or chronic motor or vocal tic disorder
(“course cohort”) and their siblings without any tic disorder
(“onset cohort”) were examined at several points in time. In the
present study, we used all participants of the “course cohort”
in the baseline sample with an established diagnosis of TS or
chronic motor or vocal tic disorder according to DSM IV-TR
criteria (29), resulting in a sample of 706 children and adolescents
between 3 and 16 years. Rater training was conducted for all
clinical assessments with a focus on the YGTSS. Furthermore,
throughout the duration of the study regular meetings with all
collaborators took place to standardize the procedures (28). For
a detailed description of the study design and procedure we refer
to Schrag et al. (28).
In the present study we used the data of the YGTSS as well as
of the following assessments:
• The Clinical Global Impression Scale Severity [CGI-S (24)]
for tics: A clinician-administered single-item tic assessment
over the past week (“How severe have the tics been during
the week preceding this visit?”), rated on a 7-point Likert scale
(range 1–7).
• The Children’s Yale–Brown Obsessive Compulsive Scale
[CY-BOCS (30)]: A semi-structured clinician-administered
interview assessing the severity of obsessions and compulsions
occurring over the past week across five areas (time,
interference, distressing nature, effort to resist, control over
obsessions and compulsions). We used the total OCD severity
score (range 0–40) including all 10 items rated on a 5-point
Likert scale (range 0–4).
• The Swanson, Nolan, and Pelham, version IV scale [SNAP-IV
(31)]: A questionnaire rated by parents assessing the severity
of ADHD symptoms over the past week, consisting in total
of 26 items on a 4-point Likert-type scale (range 0–3). We
used the composite score for ADHD symptoms (18 items; 9
items for inattention, 9 items for hyperactivity/impulsiveness)
without the 8 items assessing symptoms of Oppositional
Defiant Disorder.
• The Strengths and Difficulties Questionnaire [SDQ (32)]:
A questionnaire rated by parents assessing strengths and
difficulties over the past 2 weeks across five areas (emotional
problems, conduct problems, hyperactivity, peer problems,
prosocial behavior), consisting in total of 25 items on a 3-point
Likert-type scale (range 0–2). We used the severity score for
internalizing symptoms (10 items; 5 items of the emotional
problems subscale, 5 items of the peer problems subscale).
Statistical Analyses
All data analyses were carried out using R version 3.4.4.
To investigate a possible influence of age, analyses were
performed in the total sample (n = 706) as well as in a subgroup
of children and adolescents ≥8 years (n = 578). To check
for differences between the centers, we conducted a pair-wise
comparison (Scheffe’s test) of the average TTS of the 16 centers
(following an ANOVA). In addition, all analyses were performed
using the TS subsample (n = 624) to check for a possible bias by
combining all types of chronic tic disorders.
We calculated descriptive data of all YGTSS items and
subscales including mean, standard deviation, median, range and
skewness. The ideal would be a skewness of 0. Positive values
indicate a right skewed distribution (i.e., greater use of lower scale
scores), negative values indicate a left skewed distribution (i.e.,
greater use of higher scale scores).
To investigate the proposed factor structure (4) we used a CFA
and formulated a two-factor model: The five items comprising
each of the motor and phonic tic subscales were loaded
onto motor and phonic tic factors, respectively. The overall
impairment rating was allowed to freely load on both. We ran
the CFA using the diagonally weighted least-squares estimator
(WLSMV), an estimator suited for analyzing ordinal data.
As fit indices, we used the root mean square error of
approximation (RMSEA), the comparative fit index (CFI), and
the Tucker Lewis index (TLI). So far, no generally accepted cut-
off values for sufficient fit have been defined. For the RMSEA,
recommended cut-off values vary between RMSEA ≤ 0.06 (33)
and RMSEA ≤ 0.10 (34), for the CFI, between CFI ≥ 0.90 (35)
and CFI ≥ 0.95 (33), and for the TLI, between TLI ≥ 0.90 (36)
and TLI≥ 0.95 (33). These indices reflect the global fit of amodel.
To investigate possible local misspecifications, we additionally
used the framework proposed by Saris et al. (37). Significant
localmisspecifications indicate where deviations from the à priori
specified relationships between items and latent factors occur.
Internal consistency was assessed by calculating α and  (20).
For both, α and  the acceptable limit for multidimensional
scales would be 0.50 (38).
Convergent validity was determined by Spearman’s rank
correlations (rs) between YGTSS sum scores and the CGI-
S. Discriminant validity was determined by Spearman’s rank
correlations (rs) between YGTSS sum scores and the total
OCD severity score of the CY-BOCS, the composite score for
ADHD symptoms of the SNAP-IV as well as the severity score
for internalizing symptoms of the SDQ, respectively. Since
the YGTSS should not assess OCD, ADHD or internalizing
symptoms, but they often co-occur, low to moderate correlations
were expected.
RESULTS
After conservatively cleaning the data and excluding all subjects
from the EMTICS “course cohort” baseline sample which did
not meet the criteria for a diagnosis of TS or chronic motor
or vocal tic disorder, the sample consisted of 706 children and
adolescents (541 boys, 165 girls) with a mean age of 10.67 years
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TABLE 1 | Descriptive data of all YGTSS items as well as YGTSS subscales.
Mean SD Median Range Skew
Motor Number 2.68 1.18 2 0–5 0.00
Frequency 3.40 1.25 4 0–5 −0.74
Intensity 2.75 1.03 3 0–5 −0.52
Complexity 1.89 1.35 2 0–5 −0.05
Interference 1.61 1.20 1 0–5 0.63
Phonic Number 1.35 1.10 1 0–5 0.67
Frequency 2.16 1.62 2 0–5 −0.01
Intensity 1.80 1.37 2 0–5 0.12
Complexity 0.91 1.37 0 0–5 1.24
Interference 1.06 1.17 1 0–5 1.12
Total motor tic score 12.32 4.60 13 0–23 −0.37
Total phonic tic score 7.27 5.56 7 0–22 0.25
Total tic score (TTS) 19.60 8.62 19 0–44 0.15
Overall impairment rating 14.58 11.94 10 0–50 0.59
Global severity score (GSS) 34.17 18.29 33 0–92 0.42
(SD = 2.81 years, range 3–16 years). For none of the analyses
an age dependency was detected when comparing the results of
the subgroup (>8 years) with the results of the total sample. The
analysis of differences between centers showed no distinct site
differences regarding the TTS (data not shown). Furthermore,
there were no substantial differences between the subsample of
TS patients and the total sample (data not shown).
Descriptive data of all YGTSS items and subscales are
displayed in Table 1. The means of the TTS items ranged from
0.91 (phonic: complexity) to 3.40 (motor: frequency). All five
phonic tic items were below the theoretical scale midpoint of 2.5
with the items 4 (complexity) and 5 (interference) in particular
showing a right-skewed distribution with values >1 (but not
exceeding 2). Concerning the motor tic items, two items were
below and three above the theoretical scale midpoint of 2.5.
The values for skewness were all <1. The mean of the overall
impairment itemwas 14.58 and clearly below the theoretical scale
midpoint of 25.
Overall, 624 subjects met diagnostic criteria for TS, 76 for
chronic motor tic disorder, and six for chronic vocal tic disorder.
However, not all subjects diagnosed with TS had both motor
and phonic tics during the previous week. A total of 178/706
participants were found to have no phonic tics and 21/706 no
motor tics within the previous week.
Internal Consistency
For the internal consistency, different results were found
depending on the measure considered: When  was considered,
the TTS had a value of  = 0.58 and the GSS had a value
of  = 0.56, thus exceeding the acceptable limit of 0.50 for
multidimensional scales (38) and indicating sufficient internal
consistency. Using α, higher values were found (α=0.87 for TTS,
α =0.88 for GSS) indicating a high internal consistency (39).
Factor Structure
Using the estimator for ordinal data (WLSMV), the following fit
indices were obtained for the proposed two factor-model model:
RMSEA = 0.09 [0.08; 0.10], CFI = 0.90, TLI = 0.87 indicating
a marginal fit. As displayed in Figure 1, motor tic items showed
medium to high loadings between 0.62 and 0.74 on the “motor
tics factor,” and phonic items showed high loadings between 0.70
and 0.87 on the “phonic tics factor.” The overall impairment
rating showed a low tomedium loading of 0.46 on the “motor tics
factor” and a very low loading of 0.24 on the “phonic tics factor.”
The correlation between the two factors was 0.49.
In the subsequent evaluation of local misspecifications,
significantly correlated errors between the items (between and
within factors) were found. The error correlations of at least
13 item pairs were clearly identified as misspecifications (see
Supplementary Material for detailed information).
Due to the only marginal fit, we subsequently conducted an
EFA, but also found a two-factor solution and failed to identify a
satisfying interpretable alternative model (data not shown).
Convergent and Discriminant Validity
As shown in Table 2, correlations of the YGTSS sum scores
with the GCI-S for tics range from rs = 0.50 to rs = 0.65,
indicating a sufficient convergent validity (≥0.50), but not
reaching an excellent convergent validity of >0.70 (40). As
expected, correlations with the total OCD score of the CY-BOCS,
the composite score for ADHD symptoms of the SNAP-IV and
the severity score for internalizing symptoms of the SDQ were
low to moderate (rs = 0.21–0.27 for the total OCD severity score;
rs = 0.20–0.25 for the composite score for ADHD symptoms; rs
= 0.17–0.30 for the severity score for internalizing symptoms),
suggesting adequate discriminant validity (see Table 2).
DISCUSSION
This study aimed to investigate the psychometric quality of the
YGTSS in a large sample to overcome limitations of previous
studies. Our results confirm a factor structure with the two
factors “motor tics” and “phonic tics” with five items each.
Loadings of the impairment rating item were low, supporting
the separate use of the TSS and the impairment rating instead
of the sum score GSS. However, correlated measurement errors
were identified which worsened themodel fit and offered possible
explanations for inconsistent results concerning factorial validity
and internal consistency arising from previous studies. Internal
consistency was found to be lower than in previous studies,
but still acceptable. Convergent validity was acceptable and
discriminant validity was good to very good indicating that the
YGTSS is suitable to differentiate between tics and comorbid
conditions such as ADHD and OCD as well as frequently co-
occurring problems like internalizing symptoms.
Our analysis of the factor structure confirms that the five
“motor items” as well as the five “phonic items” each represent
separate common factors. However, the loadings of the overall
impairment rating (that was allowed to load on both factors)
were low, suggesting that this item does not sufficiently “fit” the
others, i.e., they probably do not measure the same construct.
When combining all items by calculating the GSS, the overall
impairment rating has a considerable influence, since its intervals
between anchor points differ from the other items (0–50 instead
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FIGURE 1 | Two-factorial structure of the YGTSS including loadings, inter-factor correlation and correlated errors. phonic1, phonic tics: number; phonic2, phonic tics:
frequency; phonic3, phonic tics: intensity; phonic4, phonic tics: complexity; phonic tics: interference; motor1, motor tics: number; motor2, motor tics: frequency;
motor3, motor tics: intensity; motor4, motor tics complexity; motor5, motor tics: interference; impair, overall impairment rating; e, error. Results of the Confirmatory
Factor Analysis are shown including loadings of the phonic and motor items on the specified factors. In addition, loadings of the overall impairment rating are illustrated,
which was allowed to load on both factors. Finally, inter-factor correlation and significant correlations between measurement errors of the items are displayed.
of 0–5) leading to a contribution of 50% to the GSS. Especially in
view of this fact, our findings support the current clinical practice
not to merge the impairment rating item with the TTS.
Altogether, the model reached a marginal fit that was just
above the threshold for acceptable fit. Despite the low loadings
of the impairment rating, a much better fit would have been
expected due to the high loadings of all other items on the
respective factors. Similar to Storch et al. (7), we demonstrated
the unusual combination of a marginal fit despite mostly high
loadings. While Storch et al. (7) assumed that this was due to
their small sample, for the present study this explanation can be
excluded since we included a large sample. In order to go a step
further, we therefore investigated possible local misspecifications
and identified significant correlated measurement errors that
can be regarded as a plausible reason for the worsened fit of
the model.
Moreover, the finding of correlated measurement errors also
offers a possible explanation for the results regarding the analysis
of internal consistency: An important assumption for using α is
that the errors of the items are uncorrelated, as α can be strongly
overestimated by many positively correlated errors (12, 41, 42).
The use of  does not require uncorrelated errors, so there is no
reason to assume that the results for  are biased by correlated
TABLE 2 | Spearman rank correlations (rs) between the YGTSS sum scores and









CGI-S 0.62** 0.50** 0.65** 0.52** 0.64**
CY-BOCS 0.22** 0.25** 0.27** 0.21** 0.26**
SNAP-IV 0.20** 0.22** 0.24** 0.21** 0.25**
INT 0.17** 0.28** 0.27** 0.26** 0.30**
TTS, Total Tic Score; GSS, Global Severity Score; CGI-S, Clinical Global Impression
Severity; CY-BOCS, Children’s Yale–Brown Obsessive–Compulsive Scale; SNAP-IV,
Swanson, Nolan, and Pelham IV scale; INT, Internalizing Symptoms of the Strengths and
Difficulties Questionnaire (SDQ); **p < 0.001.
errors. Accordingly, we found a clear discrepancy between α
and  probably demonstrating the bias when using α under
unfulfilled assumptions. Using, the internal consistency turned
out to be markedly lower than for α, but still acceptable.
Considering the results for factorial validity and internal
consistency, our data suggest that discrepant previous findings
demonstrating on the one hand high internal consistency (4, 6–
8) and high loadings of items on the respective factors (7), but
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on the other hand insufficient model fit (7), could be related
to correlated measurement errors. Based on our results, it can
be hypothesized that in previous studies not only the internal
consistency has been overestimated by using α under unfulfilled
assumptions, but also correlated measurement errors worsened
the model fit.
Consequently, it is important to understand potential causes
of these correlated measurement errors and the possible
implications they could have for the YGTSS. In general, the
presence of several correlated measurement errors indicates
that the affected items share systematic variance independent
of the specified tic severity due to the influence of one or
even more external factors. This may lead to limitations in
the accuracy of the assessment instrument and may therefore
have a serious confounding influence on empirical results (43).
However, systematic error variance may be acceptable and
error correlations can be included in the model (23) if there
is an “innocuous” explanation (44). For example, when using
different assessment modalities (i.e., self-report, observation)
“method covariance” can occur, which can be added to the model
as an additional method factor. The integration of correlated
measurement errors is critical if no theoretical justification can
be found and they are simply added post hoc without testing
the revised model on a new dataset (45, 46). Since we identified
a large number of correlated errors of the YGTSS without any
clear pattern, no theoretical justification was possible. When
speculating about such correlated errors, it is plausible that the
item “number” of tics (item 1) is probably a precondition for
the item “complexity” of tics (item 4), which would represent
a shared variance that is unrelated to overall tic severity.
In addition, it can be assumed that correlated errors are
(at least partly) caused by additional problematic influences.
Interviewers may have difficulties differentiating between the
different domains of the YGTSS. This could particularly affect
less experienced raters since the YGTSS was designed for use by
highly trained and experienced interviewers (47).
However, in general, the higher the complexity of a scale,
the more individuals tend to respond consistently to similar
questions that are actually intended to assess different aspects
(44) resulting in a consistency effect. Accordingly, the finding
of correlated errors should always give reason to check
whether the complexity of a scale can be reduced. This
is in line with general considerations in scale development
including the recommendation to avoid any confusion and
complexity wherever possible (48, 49). Accordingly, rating scale
categorizations (e.g., anchor points) should be well-defined,
mutually exclusive, univocal and exhaustive (50). The anchor
point descriptions of the YGTSS do not entirely meet these
criteria. For example, for the item “frequency” of tics (item 2), the
definitions of category 2 “occasionally” (“Specific tic behaviors
are usually present on a daily basis, but there are long tic-free
intervals during the day. Bouts of tics may occur on occasion and
are not sustained for more than a few minutes at a time”) and
category 3 “frequent” (“Specific tic behaviors are present on a
daily basis. Tic free intervals as long as 3 h are not uncommon.
Bouts of tics occur regularly but may be limited to a single
setting”) have the following limitations: They are relatively long,
they are largely overlapping and therefore difficult to distinguish,
and they use imprecise wordings such as “not uncommon.” In
addition, multiple different aspects are combined in one single
item such as presence on a daily basis, tic-free intervals, and
limitation to settings.
The analysis of the discriminant and convergent validity
showed good to very good or acceptable results. The results
of the discriminant validity of the YGTSS sum scores were
in line with our expectations demonstrating low to medium
correlations with assessments of ADHD, OCD, and internalizing
symptoms. The correlations of the YGTSS sum scores with
the CGI-S for tics (as measurement of convergent validity)
suggest sufficient convergent validity (≥0.50), but do not reach
an excellent convergent validity of >0.70 (40). However, it
must be taken into account that—by definition—it is difficult
to determine convergent validity for an assessment considered
the gold standard measurement such as the YGTSS. In addition,
the CGI-S was the only rating used to examine the convergent
validity. Therefore, it would be beneficial to use further
measures of convergent validity like self-assessments or parent-
rated instruments (e.g., Tourette’s Disorder Scale—Parent Rated
[TODS–PR (51)] as well as to pay more attention to other forms
of validity—such as predictive validity—in the future.
The recently published YGTSS-R included minor
modifications primarily concerning the domains “frequency”
and “complexity” of tics (8). These changes have been suggested
because for both domains skewed distributions in the same
direction were found not only for motor, but also for phonic tic
items: For the domain “frequency,” both motor and vocal tics
showed a negative skewness (greater use of higher scale scores)
and for the domain “complexity,” both motor and vocal tics
showed a positive skewness (greater use of lower scale scores)
(8). Since we found similar (although less pronounced) results
for the items of “complexity,” the proposed modifications seem
to be reasonable. However, regarding the domain “frequency,”
our results showed a skewed distribution for the motor, but not
the phonic item, which in turn is an argument against modifying
these anchor point descriptions. When taking all items of the
YGTSS into consideration, similar to McGuire et al.’s data (8)
we found that for some items the scoring range is not fully
exhausted supporting the possible benefit of modifications. But
the distributions for motor and phonic tic items often differ,
which is a central problem for meaningful modifications of the
anchor point descriptions since they refer to the assessment of
both kinds of tics. Furthermore, our results suggest the benefits
of an additional decrease of complexity by e.g., simplifying the
anchor point descriptions or reducing the number of domains.
Moreover, alternative approaches such as regression models
or models of probabilistic test theory might be useful to
explore alternative structures for the YGTSS in the future. To
further improve, standardize, and simplify the assessment of
tics, utilization of alternative measurement modalities might
additionally be helpful such as video records, tracking bracelets,
and smartphone apps.
The following limitations of the study should be noted: (i)
the sample consisted of children and adolescents up to the age
of 16 only. Since no differences in the clinical characteristics of
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tics between children/adolescents and adults have been shown
so far (8), we do not believe that this has influenced our
results; (ii) although diagnosed with TS, a quarter of participants
had no phonic tics during the week before the assessment.
Nevertheless we decided to investigate the theoretically assumed
two factor structure of the YGTSS with all participants, since
the target group of the YGTSS includes all tic disorders (4).
In line with this, sub-analyses including only the TS subsample
resulted in similar findings; (iii) the mean overall impairment
rating was relatively low suggesting that our sample comprised
less affected children/adolescents; (iv) the available dataset did
not allow to determine inter-rater reliability. Nevertheless, we
assume a high quality of the raters since only leading European
experts participated in this study and a rater training was
performed (28); (v) EMTICS was designed as a multi-center
study. Accordingly, merging of data may have caused errors
or distortions despite standardization data management and
cleaning. We have decided not to correct any site differences
statistically (e.g., by using a regression model), since the present
study focused on the quality of the YGTSS, which relies, among
other things, on providing the same results under all conditions.
Removing site differences would run the risk of artificially
glossing over the results. Moreover, it cannot be ruled out that
participants who were actually affected to a different extent were
included in the different centers; (vi) due to the study design,
translations of the YGTSS in various languages had to be used,
although only for the Spanish version has been validated so far
(52). Since large sample sizes are essential for accurate estimates
(especially within the CFA and for ), separate analyses for each
language were not possible. Thus, validations of all versions of the
YGTSS are highly appreciated in further studies.
In conclusion, our findings suggest acceptable psychometric
qualities of the YGTSS. The results showed good discriminant
validity, confirming the strength of the YGTSS in differentiating
between tic severity and comorbid conditions. Given the fact that
the YGTSS is the current gold standard for tic assessment (5) and
widely used in all kind of research including treatment studies, it
is also important to be aware of its limitations. Our data revealed
correlated measurement errors presumably due to unexplained
intercorrelations between domains and anchor points. Although
our results support at least some of the modifications already
suggested by the recently published YGTSS-R (8), based on our
data, additional investigations and modifications are desirable
to further improve the quality of the scale. Furthermore,
our results corroborate clinical practice of separate use of
the TSS and the impairment rating instead of the sum
score GSS.
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